Epidemiology

  1. The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021

    1. Joshua G. Petrie
    2. Marisa C. Eisenberg
    3. Adam S. Lauring
    4. Julie Gilbert
    5. Samantha M. Harrison
    6. Peter M. DeJonge
    7. Emily T. Martin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. The decay of coronavirus in sewage pipes and the development of a predictive model for the estimation of SARS-CoV-2 infection cases based on wastewater surveillance

    1. Songzhe Fu
    2. Qingyao Wang
    3. Fenglan He
    4. Can Zhou
    5. Jin Zhang
    6. Wen Xia

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sector

    1. Carl A. Whitfield
    2. Martie van Tongeren
    3. Yang Han
    4. Hua Wei
    5. Sarah Daniels
    6. Martyn Regan
    7. David W. Denning
    8. Arpana Verma
    9. Lorenzo Pellis
    10. Ian Hall
    11. with the University of Manchester COVID-19 Modelling Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Mobility was a significant determinant of reported COVID-19 incidence during the Omicron Surge in the most populous U.S. Counties

    1. Jeffrey E. Harris

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study

    1. Hiam Chemaitelly
    2. Houssein H Ayoub
    3. Sawsan AlMukdad
    4. Peter Coyle
    5. Patrick Tang
    6. Hadi M Yassine
    7. Hebah A Al-Khatib
    8. Maria K Smatti
    9. Mohammad R Hasan
    10. Zaina Al-Kanaani
    11. Einas Al-Kuwari
    12. Andrew Jeremijenko
    13. Anvar Hassan Kaleeckal
    14. Ali Nizar Latif
    15. Riyazuddin Mohammad Shaik
    16. Hanan F Abdul-Rahim
    17. Gheyath K Nasrallah
    18. Mohamed Ghaith Al-Kuwari
    19. Adeel A Butt
    20. Hamad Eid Al-Romaihi
    21. Mohamed H Al-Thani
    22. Abdullatif Al-Khal
    23. Roberto Bertollini
    24. Laith J Abu-Raddad

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A log-odds system for waning and boosting of COVID-19 vaccine effectiveness

    1. Joshua Szanyi
    2. Tim Wilson
    3. Nick Scott
    4. Tony Blakely

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Epidemic Model with Direct and Indirect Transmission modes and Two Delays

    1. F. Najm
    2. R. Yafia
    3. M. A. Aziz Alaoui
    4. A. Aghriche

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis

    1. Caroline Korves
    2. Hector S. Izurieta
    3. Jeremy Smith
    4. Gabrielle M. Zwain
    5. Ethan I. Powell
    6. Abirami Balajee
    7. Kathryn M. Ryder
    8. Yinong Young-Xu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Comparison of the 2021 COVID-19 roadmap projections against public health data in England

    1. Matt J. Keeling
    2. Louise Dyson
    3. Michael J. Tildesley
    4. Edward M. Hill
    5. Samuel Moore

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Conditions of Confinement in U.S. Carceral Facilities during COVID-19: Individuals Speak: Incarcerated during the COVID-19 Epidemic (INSIDE)

    1. Nicole Cassarino
    2. Harika Dabbara
    3. Carla B. Monteiro
    4. Arthur Bembury
    5. Leslie Credle
    6. Uma Grandhi
    7. Samantha White
    8. Monik C. Jiménez

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 108 of 464 Next